US Stock MarketDetailed Quotes

UBX Unity Biotechnology

Watchlist
  • 1.3999
  • +0.0499+3.70%
Trading Aug 6 11:52 ET
23.50MMarket Cap-524P/E (TTM)

Unity Biotechnology Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
54.20%-5.18M
29.24%-37.09M
35.54%-7.58M
34.47%-7.11M
25.29%-11.08M
24.42%-11.32M
-16.32%-52.41M
-133.66%-11.75M
6.06%-10.86M
-10.84%-14.84M
Net income from continuing operations
-9.68%-5.79M
10.36%-39.86M
-216.21%-1.5M
-11.57%-15.29M
-35.43%-17.79M
72.09%-5.28M
26.77%-44.47M
112.05%1.29M
16.68%-13.71M
26.30%-13.14M
Operating gains losses
74.65%-1.39M
70.27%-5.17M
66.59%-5.66M
----
----
-2,659.30%-5.49M
-14,036.59%-17.39M
---16.94M
---96K
---151K
Depreciation and amortization
-31.00%227K
-45.78%1.18M
-43.52%231K
-42.43%308K
-48.44%314K
-47.53%329K
-24.31%2.18M
-39.05%409K
-24.44%535K
-18.15%609K
Other non cash items
-781.82%-300K
55.13%-367K
-410.71%-261K
36.89%-219K
127.49%69K
114.47%44K
-186.74%-818K
139.07%84K
-118.28%-347K
33.07%-251K
Change In working capital
135.29%939K
-329.65%-4.39M
-151.55%-815K
-50.48%309K
71.23%-1.22M
-358.85%-2.66M
-61.97%-1.02M
-28.62%1.58M
158.70%624K
-535.07%-4.26M
-Change in prepaid assets
197.44%1.22M
-1,305.80%-1.66M
-87.01%194K
158.85%276K
11.14%-885K
-1,235.45%-1.25M
-89.29%138K
12.17%1.49M
-203.08%-469K
52.18%-996K
-Change in payables and accrued expense
86.06%-200K
-125.60%-2.65M
-1,479.69%-883K
-97.47%28K
88.92%-363K
-254.63%-1.44M
61.20%-1.18M
120.65%64K
178.34%1.11M
-207.80%-3.28M
-Change in other current assets
-439.13%-78K
-289.74%-74K
-625.00%-126K
135.71%5K
60.00%24K
64.29%23K
142.86%39K
71.43%24K
86.67%-14K
--15K
-Change in other current liabilities
----
--0
--0
--0
----
----
-102.33%-23K
--0
--0
-95.65%1K
Cash from discontinued investing activities
Operating cash flow
54.20%-5.18M
29.24%-37.09M
35.54%-7.58M
34.47%-7.11M
25.29%-11.08M
24.42%-11.32M
-16.32%-52.41M
-133.66%-11.75M
6.06%-10.86M
-10.84%-14.84M
Investing cash flow
Cash flow from continuing investing activities
-133.79%-7.19M
346.47%60.5M
8,013.09%15.11M
139.33%14.25M
-44.31%9.85M
465.79%21.28M
-162.43%-24.55M
-102.10%-191K
-311.23%-36.23M
1,907.25%17.69M
Net PPE purchase and sale
--19K
-63.12%104K
65.22%114K
-116.39%-10K
--0
--0
244.62%282K
1,085.71%69K
162.24%61K
----
Net investment purchase and sale
-133.88%-7.21M
343.25%60.39M
5,869.23%15M
139.29%14.26M
-43.82%9.85M
465.79%21.28M
-162.84%-24.83M
-102.86%-260K
-310.38%-36.29M
2,042.52%17.54M
Cash from discontinued investing activities
Investing cash flow
-133.79%-7.19M
346.47%60.5M
8,013.09%15.11M
139.33%14.25M
-44.31%9.85M
465.79%21.28M
-162.43%-24.55M
-102.10%-191K
-311.23%-36.23M
1,907.25%17.69M
Financing cash flow
Cash flow from continuing financing activities
0
-129.05%-16.34M
182.73%4.39M
-136.59%-18.38M
-2,002.17%-2.63M
-93.67%274K
169.80%56.24M
-77.38%1.55M
1,631.72%50.22M
-86.46%138K
Net issuance payments of debt
----
---20M
--0
---16.77M
----
----
--0
--0
--0
----
Net common stock issuance
--0
-91.20%5.11M
24.59%4.36M
-100.10%-48K
3,884.62%518K
-93.67%274K
212.65%58.07M
-48.34%3.5M
1,631.72%50.22M
1,200.00%13K
Proceeds from stock option exercised by employees
----
-18.31%116K
47.06%25K
--0
----
----
-93.34%142K
-88.74%17K
--0
----
Net other financing activities
----
20.54%-1.56M
--0
----
----
----
-1,036.67%-1.97M
----
----
----
Cash from discontinued financing activities
Financing cash flow
--0
-129.05%-16.34M
182.73%4.39M
-136.59%-18.38M
-2,002.17%-2.63M
-93.67%274K
169.80%56.24M
-77.38%1.55M
1,631.72%50.22M
-86.46%138K
Net cash flow
Beginning cash position
51.84%20.7M
-60.32%13.63M
-63.48%8.77M
-4.18%20.01M
33.40%23.87M
-60.32%13.63M
78.42%34.35M
2.48%24.02M
39.78%20.89M
-36.75%17.89M
Current changes in cash
-220.88%-12.37M
134.11%7.07M
214.79%11.93M
-458.71%-11.24M
-228.64%-3.85M
162.19%10.24M
-237.23%-20.72M
-195.23%-10.39M
-63.11%3.13M
122.45%3M
End cash Position
-65.12%8.33M
51.84%20.7M
51.84%20.7M
-63.48%8.77M
-4.18%20.01M
33.40%23.87M
-60.32%13.63M
-60.32%13.63M
2.48%24.02M
39.78%20.89M
Free cash flow
54.20%-5.18M
29.35%-37.1M
35.74%-7.58M
34.66%-7.13M
25.35%-11.08M
24.42%-11.32M
-16.03%-52.51M
-134.07%-11.79M
6.44%-10.9M
-10.30%-14.85M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 54.20%-5.18M29.24%-37.09M35.54%-7.58M34.47%-7.11M25.29%-11.08M24.42%-11.32M-16.32%-52.41M-133.66%-11.75M6.06%-10.86M-10.84%-14.84M
Net income from continuing operations -9.68%-5.79M10.36%-39.86M-216.21%-1.5M-11.57%-15.29M-35.43%-17.79M72.09%-5.28M26.77%-44.47M112.05%1.29M16.68%-13.71M26.30%-13.14M
Operating gains losses 74.65%-1.39M70.27%-5.17M66.59%-5.66M---------2,659.30%-5.49M-14,036.59%-17.39M---16.94M---96K---151K
Depreciation and amortization -31.00%227K-45.78%1.18M-43.52%231K-42.43%308K-48.44%314K-47.53%329K-24.31%2.18M-39.05%409K-24.44%535K-18.15%609K
Other non cash items -781.82%-300K55.13%-367K-410.71%-261K36.89%-219K127.49%69K114.47%44K-186.74%-818K139.07%84K-118.28%-347K33.07%-251K
Change In working capital 135.29%939K-329.65%-4.39M-151.55%-815K-50.48%309K71.23%-1.22M-358.85%-2.66M-61.97%-1.02M-28.62%1.58M158.70%624K-535.07%-4.26M
-Change in prepaid assets 197.44%1.22M-1,305.80%-1.66M-87.01%194K158.85%276K11.14%-885K-1,235.45%-1.25M-89.29%138K12.17%1.49M-203.08%-469K52.18%-996K
-Change in payables and accrued expense 86.06%-200K-125.60%-2.65M-1,479.69%-883K-97.47%28K88.92%-363K-254.63%-1.44M61.20%-1.18M120.65%64K178.34%1.11M-207.80%-3.28M
-Change in other current assets -439.13%-78K-289.74%-74K-625.00%-126K135.71%5K60.00%24K64.29%23K142.86%39K71.43%24K86.67%-14K--15K
-Change in other current liabilities ------0--0--0---------102.33%-23K--0--0-95.65%1K
Cash from discontinued investing activities
Operating cash flow 54.20%-5.18M29.24%-37.09M35.54%-7.58M34.47%-7.11M25.29%-11.08M24.42%-11.32M-16.32%-52.41M-133.66%-11.75M6.06%-10.86M-10.84%-14.84M
Investing cash flow
Cash flow from continuing investing activities -133.79%-7.19M346.47%60.5M8,013.09%15.11M139.33%14.25M-44.31%9.85M465.79%21.28M-162.43%-24.55M-102.10%-191K-311.23%-36.23M1,907.25%17.69M
Net PPE purchase and sale --19K-63.12%104K65.22%114K-116.39%-10K--0--0244.62%282K1,085.71%69K162.24%61K----
Net investment purchase and sale -133.88%-7.21M343.25%60.39M5,869.23%15M139.29%14.26M-43.82%9.85M465.79%21.28M-162.84%-24.83M-102.86%-260K-310.38%-36.29M2,042.52%17.54M
Cash from discontinued investing activities
Investing cash flow -133.79%-7.19M346.47%60.5M8,013.09%15.11M139.33%14.25M-44.31%9.85M465.79%21.28M-162.43%-24.55M-102.10%-191K-311.23%-36.23M1,907.25%17.69M
Financing cash flow
Cash flow from continuing financing activities 0-129.05%-16.34M182.73%4.39M-136.59%-18.38M-2,002.17%-2.63M-93.67%274K169.80%56.24M-77.38%1.55M1,631.72%50.22M-86.46%138K
Net issuance payments of debt -------20M--0---16.77M----------0--0--0----
Net common stock issuance --0-91.20%5.11M24.59%4.36M-100.10%-48K3,884.62%518K-93.67%274K212.65%58.07M-48.34%3.5M1,631.72%50.22M1,200.00%13K
Proceeds from stock option exercised by employees -----18.31%116K47.06%25K--0---------93.34%142K-88.74%17K--0----
Net other financing activities ----20.54%-1.56M--0-------------1,036.67%-1.97M------------
Cash from discontinued financing activities
Financing cash flow --0-129.05%-16.34M182.73%4.39M-136.59%-18.38M-2,002.17%-2.63M-93.67%274K169.80%56.24M-77.38%1.55M1,631.72%50.22M-86.46%138K
Net cash flow
Beginning cash position 51.84%20.7M-60.32%13.63M-63.48%8.77M-4.18%20.01M33.40%23.87M-60.32%13.63M78.42%34.35M2.48%24.02M39.78%20.89M-36.75%17.89M
Current changes in cash -220.88%-12.37M134.11%7.07M214.79%11.93M-458.71%-11.24M-228.64%-3.85M162.19%10.24M-237.23%-20.72M-195.23%-10.39M-63.11%3.13M122.45%3M
End cash Position -65.12%8.33M51.84%20.7M51.84%20.7M-63.48%8.77M-4.18%20.01M33.40%23.87M-60.32%13.63M-60.32%13.63M2.48%24.02M39.78%20.89M
Free cash flow 54.20%-5.18M29.35%-37.1M35.74%-7.58M34.66%-7.13M25.35%-11.08M24.42%-11.32M-16.03%-52.51M-134.07%-11.79M6.44%-10.9M-10.30%-14.85M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg